By Mike Curley ( December 16, 2020, 5:08 PM EST) -- Sanofi is asking the Fifth Circuit not to revive a suit by a patient alleging the company failed to warn that its chemotherapy drug Taxotere carried a risk of permanent hair loss, saying the patient's physician testified that a different warning would not have affected his decision to administer the drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.